Speaker Profile
Ph.D., CO-Founder & CSO, Rubedo Life Sciences
Biography
Marco Quarta, PhD, is a scientist, biotechnology executive, and entrepreneur advancing precision medicine for aging and age-related disease. He is the founding CEO and current Chief Scientific Officer of Rubedo Life Sciences, where he leads the development of first-in-class therapeutics that selectively target pathological senescent cells and restore tissue homeostasis.
From 2008 to 2018, Dr. Quarta led translational research at Stanford University and the VA Palo Alto Center for Tissue Regeneration, Repair, and Restoration, integrating stem cell biology, regenerative medicine, biomarker discovery, and clinical translation. He has authored more than 40 peer-reviewed publications and patents across aging biology, cellular rejuvenation, and tissue repair.
Dr. Quarta also co-founded Turn Biotechnologies, Wetware Concepts, and YEBN. He serves on advisory boards for CIRM’s Cal Poly Bridge Program and the Center for Healthcare Innovation, and is President and co-founder of the Phaedon Institute, advancing longevity medicine through cross-sector collaboration and data-driven approaches to healthy human longevity worldwide.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Nir Barzilai, Albert Einstein & Mike Snyder, Stanford
PMWC Award Ceremony
• Alexander (Zan) Fleming, Hevolution Foundation (Pioneer)
• Daniel Drucker, Sinai Health (Pioneer)
• Andrea Maier, NUS Yong Loo Lin School of Medicine (Luminary)
Featured Speakers
• Nir Barzilai, Albert Einstein
• Mike Snyder, Stanford
• Andrea Maier, NUS Yong Loo Lin School of Medicine
• Sara Espinoza, Cedars-Sinai
• Brian Kennedy, Buck Institute
• John Newman, Buck Institute / UCSF
• Marco Quarta, Rubedo Life Sciences
• Maria Dermit, Novo Nordisk
• Alan Shuldiner, Regeneron
• David Furman, Stanford
• Steve Horvath, UCLA
• Daniel Belsky, Columbia
• Ahmed Metwally, Google
• Lee Hood, Phenome Health / ISB
• George Slavich, UCLA
Targeting Aging Biology
What is actually druggable today, and what remains wishful thinking.
From Metabolism to Longevity: GLP-1 and Beyond
Incretins reshaping cardiometabolic prevention and healthy aging.
Which Aging Measures Matter?
Biological-age measures and biomarkers that can change clinical decisions.
Wearables & Digital Biomarkers at Scale
Continuous phenotyping and longitudinal signals in real-world aging.
Clinical Translation
Trials, endpoints, regulation, and the hard road to credible longevity medicine.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
